Cognition Disorders Recruiting Phase 2 Trials for Acetylsalicylic acid (DB00945)

Also known as: Cognitive Disorder / Cognitive Disorders / Cognition Disorder / Cognitive Dysfunction / Cognitive Dysfunctions / Cognitive disorder (disorder)

IndicationStatusPhase
DBCOND0027877 (Cognition Disorders)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04219774NeuroCognition After Carotid RecanalizationTreatment